STOCK TITAN

Organigram Holdings Inc. Common Shares - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

News
Rhea-AI Summary

Organigram Holdings Inc. (NASDAQ: OGI) has reported significant market share growth, increasing from 3.9% in January 2021 to 7.7% by September 2021, positioning itself as the #4 licensed producer in Canada. The company acquired The Edibles and Infusions Corporation to expand its product offerings, resulting in successful new product launches. It has resumed shipments to Canndoc in Israel, and signed a supply agreement with Yukon Liquor Corporation, thus expanding its reach across Canada. Additionally, there has been a board member update with the resignation of Jeyan Heper.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
-
Rhea-AI Summary

Organigram Holdings Inc. has received a receipt for a final short form Base Shelf Prospectus across Canada, allowing it to distribute up to C$500,000,000 in various securities over 25 months. A Registration Statement is also filed with the SEC, though it’s not yet effective. This shelf registration offers the Company flexibility for future financing opportunities.

Investors should note, however, that no offers can be accepted until the registration becomes effective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.25%
Tags
none
-
Rhea-AI Summary

Organigram Holdings Inc. has launched SHRED’ems, a new line of cannabis-infused gummies, achieving the top market share in the edibles category in Prince Edward Island within just two weeks. These gummies are an extension of the popular SHRED product line and are competitively priced, available in three all-natural flavors. This launch marks a significant milestone and demonstrates the potential for growth in the rapidly expanding edibles market, as 74% of this category comprises gummies. The product is manufactured by The Edibles & Infusions Corporation, an acquisition from April 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
none
Rhea-AI Summary

Organigram Holdings has launched Edison Cannabis Co. JOLTS, Canada’s first flavoured high potency THC lozenge. Each pack contains 10 mint-flavoured lozenges, with 10 mg of THC each, totaling 100 mg. This product aims to meet the demand for high potency and convenient cannabis options, appealing to both current consumers and those from the legacy market. Designed for sublingual absorption, Edison JOLTS allows for quicker effects. Currently available in Ontario, it will roll out to other retailers soon, reinforcing Organigram’s commitment to innovation and consumer satisfaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
-
Rhea-AI Summary

Organigram Holdings has appointed Beena Goldenberg as the new Chief Executive Officer, effective September 9, 2021. Goldenberg, a seasoned leader with over 30 years of experience, previously served as CEO of The Supreme Cannabis Company, achieving 50% growth in her first year. Her leadership is expected to enhance Organigram's market position in the evolving cannabis industry. The company focuses on producing high-quality cannabis and expanding its global footprint. Goldenberg's expertise will support product innovation and value generation for shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.49%
Tags
management
-
Rhea-AI Summary

Organigram Holdings is launching the Cannabis Innovators Panel, an initiative to gain real-time insights into consumer preferences from 2,500 participants across Canada. This consumer panel aims to enhance product development by obtaining feedback on cannabis products like vapes, edibles, and pre-rolls. According to SVP Megan McCrae, engaging with consumers is vital for creating innovative, consumer-centric products. Organigram operates both domestically and internationally, focusing on high-quality cannabis production.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
none
Rhea-AI Summary

Organigram Holdings announced its Q3 2021 financial results, reporting a 31% increase in gross revenue to $29.1 million and a 13% rise in net revenue to $20.3 million compared to Q3 2020. The company improved its gross margin to $2.1 million from a loss of $50.2 million last year. Notably, a net loss of $4 million was significantly better than the previous year’s loss of $89.9 million. Q4 2021 is projected to see revenue growth supported by a strong market outlook and new product launches, including high-margin dried flower strains.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.94%
Tags
-
Rhea-AI Summary

Organigram Holdings Inc. (NASDAQ: OGI) announced it will report its earnings for the third quarter Fiscal 2021 on July 13, 2021, before market open. The earnings call is scheduled for 8:00 am Eastern Time on the same day. Investors can register for the call via a provided link and access a replay within 24 hours post-call. Organigram focuses on high-quality indoor cannabis production and has established various brands, while also aiming to expand its international presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary

Organigram Holdings (TSX: OGI, NASDAQ: OGI) announces plans to recruit up to 75 positions across various departments including Operations, Production, and Sales. This expansion accompanies the launch of the Center of Excellence, developed in collaboration with BAT, aimed at innovating cannabis vapour and oral products with an initial focus on CBD. The company emphasizes its commitment to community and quality workforce. Additionally, a career fair will be hosted on June 5, 2021, at its Moncton facility to attract potential job seekers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.94%
Tags
none
Rhea-AI Summary

Organigram Holdings Inc. (TSX: OGI) has appointed Megan McCrae as the new Senior Vice President of Marketing and Communications, effective immediately. McCrae brings 17 years of experience in consumer packaged goods marketing and sales, with a notable role as CMO at Aphria Inc. where she led brand and product strategy. Her background also includes ten years with Japan Tobacco International and advocacy efforts as Board Chair for the Cannabis Council of Canada. Her expertise aims to enhance Organigram’s marketing efforts across Canada, promoting growth and strategic planning for its cannabis brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management

FAQ

What is the current stock price of Organigram Holdings Common Shares (OGI)?

The current stock price of Organigram Holdings Common Shares (OGI) is $1.52 as of November 22, 2024.

What is the market cap of Organigram Holdings Common Shares (OGI)?

The market cap of Organigram Holdings Common Shares (OGI) is approximately 166.1M.

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.

Organigram Holdings Inc. Common Shares

Nasdaq:OGI

OGI Rankings

OGI Stock Data

166.12M
75.87M
31.32%
9.73%
2.11%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto